Table 3.

Disorders of the pentose phosphate pathway for which patients displaying cardiac manifestations have been reported (abbreviations described in Table 1).

Affected Gene	Affected Protein	Inheritance	Heart Defects & Manifestations			No. Patients Identified by Our Search	Ref.
			Cardiomyopathies	Structural Defects	Arrhythmogenic Disorders
TALDO	Transaldolase (TALDO)	AR	CM, LVH	VSD, ASD, BAV, DC, MVP, TR	HF	35	[53,55,56,57]
G6PDH	Glucose-6-phosphate dehydrogenase (G6PDH)	XL	CD	PDA, PVSD, MVS, TR	HF	>300	[58,59,60,61,62,63,64,65,66,67] (selected) *

* For G6PDH deficiency our search produced over 300 entries (articles), thus only some meaningful articles were selected.